Rusinek H, Brys M, Glodzik L, Switalski R, Tsui W-H, Haas F, McGorty K, Chen Q, de Leon MJ.  2011.  Hippocampal blood flow in normal aging measured with arterial spin labeling at 3T.. Magn Reson Med. 65(1):128-37.

Glodzik L, de Santi S, Tsui WHon, Mosconi L, Zinkowski R, Pirraglia E, Wang HYu, Li Y, Rich KE, Zetterberg H et al..  2011.  Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders.. Neurobiol Aging. 32(12):2131-41.

Berti V, Mosconi L, Glodzik L, Li Y, Murray J, de Santi S, Pupi A, Tsui W, de Leon MJ.  2011.  Structural brain changes in normal individuals with a maternal history of Alzheimer's.. Neurobiol Aging. 32(12):2325.e17-26.

Mosconi L, Rinne JO, Tsui WH, Berti V, Li Y, Wang H, Murray J, Scheinin N, Någren K, Williams S et al..  2010.  Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.. Proc Natl Acad Sci U S A. 107(13):5949-54.

Mosconi L, Glodzik L, Mistur R, McHugh P, Rich KE, Javier E, Williams S, Pirraglia E, de Santi S, Mehta PD et al..  2010.  Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's.. Biol Psychiatry. 68(10):913-21.

Mosconi L, Berti V, Glodzik L, Pupi A, de Santi S, de Leon MJ.  2010.  Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging.. J Alzheimers Dis. 20(3):843-54.

Glodzik L, de Santi S, Rich KE, Brys M, Pirraglia E, Mistur R, Switalski R, Mosconi L, Sadowski M, Zetterberg H et al..  2009.  Effects of memantine on cerebrospinal fluid biomarkers of neurofibrillary pathology.. J Alzheimers Dis. 18(3):509-13.

Zhan J, Brys M, Glodzik L, Tsui W, Javier E, Wegiel J, Kuchna I, Pirraglia E, Li Y, Mosconi L et al..  2009.  An entorhinal cortex sulcal pattern is associated with Alzheimer's disease.. Hum Brain Mapp. 30(3):874-82.

Mosconi L, Mistur R, Switalski R, Tsui WHon, Glodzik L, Li Y, Pirraglia E, de Santi S, Reisberg B, Wisniewski T et al..  2009.  FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease.. Eur J Nucl Med Mol Imaging. 36(5):811-22.

Brys M, Glodzik L, Mosconi L, Switalski R, de Santi S, Pirraglia E, Rich K, Kim BC, Mehta P, Zinkowski R et al..  2009.  Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease.. J Alzheimers Dis. 16(2):351-62.

Kamer AR, Craig RG, Pirraglia E, Dasanayake AP, Norman RG, Boylan RJ, Nehorayoff A, Glodzik L, Brys M, de Leon MJ.  2009.  TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjects.. J Neuroimmunol. 216(1-2):92-7.

King KG, Glodzik L, Liu S, Babb JS, de Leon MJ, Gonen O.  2008.  Anteroposterior hippocampal metabolic heterogeneity: three-dimensional multivoxel proton 1H MR spectroscopic imaging--initial findings.. Radiology. 249(1):242-50.

Glodzik L, King KG, Gonen O, Liu S, de Santi S, de Leon MJ.  2008.  Memantine decreases hippocampal glutamate levels: a magnetic resonance spectroscopy study.. Prog Neuropsychopharmacol Biol Psychiatry. 32(4):1005-12.

de Santi S, Pirraglia E, Barr W, Babb J, Williams S, Rogers K, Glodzik L, Brys M, Mosconi L, Reisberg B et al..  2008.  Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive decline.. Neuropsychology. 22(4):469-84.

Mosconi L, Brys M, Switalski R, Mistur R, Glodzik L, Pirraglia E, Tsui W, de Santi S, de Leon MJ.  2007.  Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism.. Proc Natl Acad Sci U S A. 104(48):19067-72.